Residual PG13 DNA Quantitation Kit SHENTEK® package size:100 Reactions Swissprot No P00533 Gene Accession

Swissprot No P00533 Gene Accession NP_005219 WB Predicted band size 134 kDa WB Positive control WB Recommended dilution 1000-5000 IHC predicted cell location Predicted cell location: Cytoplasm IHC positive control Positive control: Human liver cancer IHC Recommed dilution Recommended dilution: 50-100 Storage

Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders

Apr 2004] Swissprot No P23528 Gene Accession 1072 WB Predicted band size 19 kDa WB Positive control WB Recommended dilution 500-2000 IHC predicted cell location Predicted cell location: Cytoplasm IHC positive control Positive control: Human lung cancer IHC Recommed dilution Recommended dilution: 50-100 Storage

Immunohistochemical analysis of paraffin-embedded Human breast cancer tissue using P100524(ANKRD1 Antibody) at dilution 1/20

Residual PG13 DNA Quantitation Kit SHENTEK® package size:100 Reactions Swissprot No P00533 Gene AccessionDetection Method qPCR Assay Time Refer to manual Storage Temperature 20 C (stable for 24 months) Product Description SHENTEK Residual PG13 DNA Quantitation Kit is designed to quantify residual PG13 host cell DNA in biopharmaceutical samples at different stages (in process through final product). The kit uses quantitative PCR (qPCR) to provide a rapid, specific and reliable quantitation assay with sensitivity at the femtogram (fg) level. The kit